AIM: £4.50 (-0.05) | Nasdaq: $31.47 (+0.41)
Competitive Advantages

Household Brands

ShangYaoPai_clean
BaiYunShan
   
Shang Yao
Baiyunshan
Rx brand
(“Shanghai Medicine”)
OTC brand
(a famous scenic
area in Guangzhou)

Major commercial & production scale

~4.8 billion doses of medicine sold in 2018

~2,400 Prescription & ~900 OTC sales people

About 330 cities & towns in China

~24,400 hospitals

~88,400 doctors detailed

Leadership market shares

Market leader in the sub-categories/markets in which we compete:[1]

She Xiang Bao Xin Pill:[2]
Rx Cardiovascular TCM		 ~17%
Banlangen Granules:
OTC Anti-viral TCM		 ~54%
Fu Fang Dan Shen tablets:
OTC Angina TCM		 ~38%

JVs with 3 leading China pharma companies
     
Shanghai Pharmaceuticals
Sinopharm
Guangzhou Pharmaceuticals

Extensive domestic coverage

Our products have extensive representation:

  • Medicines Catalogue for the National Basic Medical Insurance
  • Labour Injury Insurance and Childbirth Insurance Systems
  • National Essential Medicines List, which mandates distribution of drugs in China

[1] Frost & Sullivan 2018 market share data; [2] China coronary heart disease oral Chinese patented drugs market share.